Can Type 2 diabetes be reversed?
Of the estimated 38 million Americans diagnosed with diabetes, an overwhelming majority has Type 2.
Diabetes is a chronic health condition that affects how the body turns food into energy. It develops when blood sugar levels are too high, causing the pancreas to produce insufficient insulin, which is a hormone that regulates blood sugar levels.
Lifestyle and genetic factors can lead to Type 2 diabetes, which can be prevented in most cases, according to the Centers for Disease Control and Prevention (CDC).
Risk factors for Type 2 include being overweight, having a family history, not getting enough exercise and being 45 years or older.
Type 2 diabetes is preventable, but is it reversible? Doctors say yes. Studies have shown that, with diet and exercise changes, some people may be able to return to normal blood sugar levels without medication, entering remission.
'The best way to reverse type 2 diabetes is to decrease your body's resistance to the actions of the insulin made by the pancreas,' said Dr. Patricia Peter, an assistant professor of medicine at the Yale School of Medicine, in a news release.
'For most people, this means trying to attain a healthy weight, exercising regularly, and minimizing sugars and excessive carbohydrates in your diet,' Peter added.
Doctors warn that healthy lifestyle changes must be maintained to keep blood sugar levels normal and to prevent the condition from redeveloping.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
21 minutes ago
- New York Post
What are Americans' morning struggles?
Two in five Americans are 'bad' at mornings, according to new research. The survey of 2,000 general population Americans revealed 38% agreed with this sentiment — and respondents get out of bed later than planned an average of eight times per month. Advertisement For one in 10 respondents, this happens more than 20 times per month. When they're rushing through their morning routine, after staying in bed longer than planned, respondents were most likely to skip eating breakfast (41%). But others will neglect their personal hygiene: 16% will skip showering, while 11% will go about their day without brushing their teeth. 5 The average alarm user sets two alarms in the morning, and a fifth will hit snooze at least three times before they actually get up out of bed according to new research. Ana Blazic Pavlovic – Advertisement Commissioned by Avocado Green Mattress and conducted by Talker Research, the survey also looked at respondents' alarm habits. Less than half (43%) use an alarm to wake up in the morning — and for these respondents, the results revealed their first alarm goes off at 6:33 a.m. Younger generations were more likely to rely on an alarm: While just a fifth (19%) of baby boomers set an alarm, 63% of Gen Z and millennials do the same. Across ages, the average alarm user sets two alarms in the morning, and a fifth will hit snooze at least three times before they actually get up out of bed. 5 The survey revealed that less than half of the people who participated (43%) use an alarm to wake up in the morning SWNS Advertisement The survey also split respondents by early birds and night owls to see how that impacts their alarm habits and their sleep overall. Two-thirds (67%) of early birds who use an alarm said it's 'very effective' at getting them out of bed on time — compared to just half (52%) of night owls. Early birds were more likely to use a 'standard' or preset alarm sound (70% vs. 58%), while night owls were more likely to have an 'annoying' sound — like a fire alarm or honking cars — to wake them up (20% vs. 12%). Unsurprisingly, night owls were more likely to struggle to get out of bed on time (54% vs. 17%). Night owls were also more likely to say their body needs more sleep than they're currently getting (70% vs. 55%). That's despite the two groups getting about the same amount of sleep — right around six and a half hours per night. Advertisement 'Whether you're a morning person or a night owl, quality sleep is non-negotiable,' said Laura Scott, Director of Brand Marketing at Avocado Green Mattress. 'Your natural sleep rhythm should be supported — not disrupted — by an environment designed for deep, restorative rest.' 5 51% of Americans are 'bad' at sleep due to their own anxieties keeping them awake. SWNS The top reason Americans aren't getting enough sleep? Their own worries are keeping them up (51%). That was followed by a sleep condition (like insomnia, sleep apnea, etc.) (30%) and nightmares or stress dreams (20%). Also in the top five was an uncomfortable bed or mattress making it more difficult to sleep (19%) and loud noises outside (14%) keeping respondents awake. 5 Sleep conditions, nightmares, uncomfortable mattresses, and loud noises are other significant sleep deterrents. Prostock-studio – While night owls (35%) and early birds (37%) were almost equally likely to struggle to stay asleep, night owls were more likely to face other difficulties. This included going to bed later than they 'should' in the evening (48% vs. 24%), struggling to fall asleep (44% vs. 27%) and staying in bed longer than they 'should' in the morning (25% vs. 8%). Advertisement 5 Creating a stable sleep habits is very important for daily living. Elnur – 'So many of us lie awake at night, our minds racing with worry or stress,' said Scott. 'That's why it's so important to create sleep spaces and habits that are calm and supportive — so you can wake up feeling like yourself again.' Survey methodology: Talker Research surveyed 2,000 general population Americans; the survey was commissioned by Avocado Green Mattress and administered and conducted online by Talker Research between May 9–15, 2025.
San Francisco Chronicle
39 minutes ago
- San Francisco Chronicle
Who's in charge? CDC's leadership 'crisis' apparent amid new COVID-19 vaccine guidance
WASHINGTON (AP) — There was a notable absence last week when U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced in a 58-second video that the government would no longer endorse the COVID-19 vaccine for healthy children or pregnant women. The director of the Centers for Disease Control and Prevention — the person who typically signs off on federal vaccine recommendations — was nowhere to be seen. The CDC, a $9.2 billion-a-year agency tasked with reviewing life-saving vaccines, monitoring diseases and watching for budding threats to Americans' health, is without a clear leader. 'I've been disappointed that we haven't had an aggressive director since — February, March, April, May — fighting for the resources that CDC needs,' said Dr. Robert Redfield, who served as CDC director under the first Trump administration and supported Kennedy's nomination as the nation's health secretary. $9.2 billion-a-year agency without leader as nomination awaits The leadership vacuum at a foremost federal public health agency has existed for months, after President Donald Trump suddenly withdrew his first pick for CDC director in March. A hearing for his new nominee — the agency's former acting director Susan Monarez — has not been scheduled because she has not submitted all the paperwork necessary to proceed, according to a spokesman for Sen. Bill Cassidy, R-La., who will oversee the nomination. HHS did not answer written questions about Monarez's nomination, her current role at the CDC or her salary. An employee directory lists Monarez, a longtime government employee, as a staffer for the NIH under the Advanced Research Projects Agency for Health. Instead, a lawyer and political appointee with no medical experience is 'carrying out some of the duties' of director at the agency that for seven decades has been led by someone with a medical degree. Matthew Buzzelli, who is also the chief of staff at the CDC, is 'surrounded by highly qualified medical professionals and advisors to help fulfill these duties as appropriate,' Andrew Nixon, an HHS spokesperson said in a statement. Adding to the confusion was an employee-wide email sent last week that thanked 'new acting directors who shave stepped up to the plate." The email, signed by Monarez, listed her as the acting director. It was was sent just days after Kennedy said at a Senate hearing that Monarez had been replaced by Buzzelli. The lack of a confirmed director will be a problem if a public health emergency such as the COVID-19 pandemic or a rapid uptick in measles cases hits, said Michael Osterholm, an epidemiologist at the University of Minnesota. 'CDC is a crisis, waiting for a crisis to happen,' said Osterholm. 'At this point, I couldn't tell you for the life of me who was going to pull what trigger in a crisis situation." An acting director rarely seen, and stalled decisions At CDC headquarters in Atlanta, employees say Monarez was rarely heard from between late January – when she was appointed acting director – and late March, when Trump nominated her. She also has not held any of the 'all hands' meetings that were customary under previous CDC chiefs, according to several staffers. One employee, who insisted on anonymity because they were not authorized to speak to the media and fears being fired if identified said Monarez has been almost invisible since her nomination, adding that her absence has been cited by other leaders as an excuse for delaying action. The situation already has led to confusion. In April, a 15-member CDC advisory panel of outside experts met to discuss vaccine policy. The panel makes recommendations to the CDC Director, who routinely signs off on them. But it was unclear during the meeting who would be reviewing the panel's recommendations, which included the expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. HHS officials said the recommendations were going to Buzzelli, but then weeks passed with no decision. A month after the meeting ended, the CDC posted on a web site that Kennedy had signed off on recommendations for travelers against chikungunya, a viral disease transmitted to humans by mosquitos. But there continues to be no word about a decision about the other vaccine recommendations. The problem was accentuated again last week, when Kennedy rolled out recommendations for the COVID-19 vaccine saying they were no longer recommended for healthy children or pregnant women, even though expectant mothers are considered a high-risk group if they contract the virus. Kennedy made the surprise announcement without input from the CDC advisory panel that has historically made recommendations on the nation's vaccine schedule. The CDC days later posted revised guidance that said healthy kids and pregnant women may get the shots. Nixon, the HHS spokesman, said CDC staff were consulted on the recommendations, but would not provide staffer's names or titles. He also did not provide the specific data or research that Kennedy reviewed to reach his conclusion on the new COVID-19 recommendations, just weeks after he said that he did not think 'people should be taking medical advice' from him. 'As Secretary Kennedy said, there is a clear lack of data to support the repeat booster strategy in children,' Nixon said in a statement. Research shows that pregnant women are at higher risk of severe illness, mechanical ventilation and death, when they contract COVID-19 infections. During the height of the pandemic, deaths of women during pregnancy or shortly after childbirth soared to their highest level in 50 years. Vaccinations also have been recommended for pregnant women because it passes immunity to newborns who are too young for vaccines and also vulnerable to infections. Nixon did not address a written question about recommendations for pregnant women. Kennedy's decision to bypass the the advisory panel and announce new COVID-19 recommendations on his own prompted a key CDC official who works with the committee – Dr. Lakshmi Panagiotakopoulos – to announce her resignation last Friday. 'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,' she wrote in an email seen by an Associated Press reporter. Signs are mounting that the CDC has been 'sidelined' from key decision-making under Kennedy's watch, said Dr. Anand Parekh, the chief medical adviser for The Bipartisan Policy Center. 'It's difficult to ascertain how we will reverse the chronic disease epidemic or be prepared for myriad public health emergencies without a strong CDC and visible, empowered director,' Parekh said. 'It's also worth noting that every community in the country is served by a local or state public health department that depends on the scientific expertise of the CDC and the leadership of the CDC director.'
Yahoo
an hour ago
- Yahoo
NCOA Applauds Reintroduction of Treat and Reduce Obesity Act
Bipartisan legislation would expand Medicare coverage of comprehensive obesity treatments View in browser Key Takeaways: The Treat and Reduce Obesity Act (TROA) has been reintroduced in the U.S. Senate. Reintroduction in the U.S. House of Representatives is expected soon. If passed and signed into law, TROA would require Medicare to cover anti-obesity medications, including GLP-1s, and expand access to intensive behavioral therapy for weight management. TROA has historically gained bipartisan support and was first introduced in Congress over 10 years ago. ARLINGTON, Va., June 5, 2025 /PRNewswire/ -- The National Council on Aging (NCOA), the national voice for every person's right to age well, applauds today's reintroduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the U.S. Senate. Led by Sens. Bill Cassidy, R-La., and Ben Ray Luján, D-N.M., TROA would expand Medicare coverage for the full continuum of obesity care, recognizing obesity as a chronic, treatable disease that affects 40 percent of older Americans. First introduced in 2013, TROA aims to improve Medicare by removing outdated barriers to quality obesity care. The legislation has consistently received bipartisan support, highlighting a growing agreement among policymakers about the need to tackle the nation's obesity epidemic. "Obesity is a chronic condition that has affected millions of Americans for decades, but getting adequate care remains stubbornly difficult for too many older adults," said Ramsey Alwin, NCOA President and CEO. "The reintroduction of TROA is a welcome and vital step toward ensuring all Americans have access to the full range of obesity treatments." The legislation would repeal an outdated statute that prevents Medicare Part D from covering FDA-approved obesity medications. TROA also enhances access to intensive behavioral therapy (IBT) under Medicare Part B, which under current policy can only be provided by primary care doctors. TROA expands access to IBT to ensure a broader array of health care providers, including registered dietitian nutritionists, obesity medicine specialists, endocrinologists, bariatric surgeons, clinical psychologists, and community-based providers. By expanding access to lifestyle-based interventions like IBT, TROA ensures patients with obesity will have access to the full spectrum of obesity care. Obesity is linked to over 200 medical conditions and is responsible for an estimated 400,000 deaths annually. In addition to the health impacts of obesity, it is also an expensive disease, costing an estimated $173 billion in the United States in 2019. Expanding insurance coverage of obesity treatments could help reduce the cost burden of obesity to both patients and all Americans. According to the USC Schaffer Center, access to innovative anti-obesity medicines, including GLP-1s, can produce a 13% return on investment. Another recent study found that employees taking anti-obesity medications saw reduced growth in medical cost rates over two years compared to those not taking them, resulting in lower costs for their employers in addition to significant health improvements. NCOA has advocated for older adults with obesity to be treated fairly by providers free from weight stigma and bias. With the National Consumers League, NCOA helped develop the Obesity Bill of Rights in 2024. About NCOAThe National Council on Aging (NCOA) is the national voice for every person's right to age well. Working with thousands of national and local partners, we provide resources, tools, best practices, and advocacy to ensure every person can age with health and financial security. Founded in 1950, we are the oldest national organization focused on older adults. Learn more at and @NCOAging. View original content to download multimedia: SOURCE National Council on Aging Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
